Advanced search×

The management of a completely edentulous patient with tardive dyskinesia.

Int J Prosthodont 23(3):217-20 (2010) PMID 20552086

Tardive dyskinesia (TD) is an involuntary movement disorder of neurologic origin caused by the use of neuroleptic drugs known as dopamine receptor antagonists. The condition may adversely affect prosthodontic interventions and their possible merits. In this case history description, the rigor of scrupulous history-taking and clinical evaluation of patients with TD or neurologic disorders is emphasized. The successful prosthodontic management of a 74-year-old completely edentulous TD patient is presented, with the conclusion that a prosthodontic intervention may aid symptom reduction and contribute to improvement in a TD patient's quality of life.

Version: za2963e q8za9 q8zbc q8zce q8zdc q8ze4 q8zf3 q8zg4

Similar articles you may find interesting…

  1. Feasibility of balloon sinuplasty in patients with chronic rhinosinusitis: the Graz experience.

    Rhinology 51(2):120-7 (2013) PMID 23671892

    Balloon sinuplasty (BSP) is a catheter-based technique to dilate sinus ostia and drainage pathways to create ventilation and drainage. The aim of this study was to evaluate the feasibility of BSP in routine treatment of patients suffering from chronic rhinosinusitis (CRS)....
  2. Cough reflex testing in Dysphagia following stroke: a randomized controlled trial.

    J Clin Med Res 5(3):222-33 (2013) PMID 23671548

    Significant health issues and service delivery costs are associated with post-stroke pneumonia related to dysphagia. Silent aspiration is known to increase pneumonia and mortality in this population. The utility of cough reflex testing (CRT) for reducing pneumonia in acute stroke pat...
  3. Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study: background, rationale, and study protocol.

    Transplantation Research 2(1):7 (2013) PMID 23641902

    BACKGROUND: Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantially, and one possible explanation is calcineurin inhibitor (CNI)...